Galderma
Presence
EQT is one of the...
EQT is a company listed under the stock ticker EQT (SE).
EQT has a direct presence in 14 countries.EQT has 43 subsidiaries including Acumatica, Anticimex and Atos Medical.
They are in:
- Business Services23%
- Fund14%
- Other64%
Acquisition, funding and merger involving EQT.
- Galderma is now listed under the stock ticker GALD. (posted on March 22 2024).
Executives
View the org chart displaying its 29 main executives
Most searched biographies at Galderma
- Flemming Ornskov, Chief Executive Officer
- Stuart Raetzman, Director
- Nakisa Serry, General Counsel and Chief Compliance Officer
Popular executive movements at Galderma
- Tara Loftis has joined the company as Global President, Skincare Brands (posted on January 18 2024).
Popular executive movements at EQT
- Peter Aliprantis has joined the company as Partner and Head of Private Wealth, Americas (posted on April 23 2024).
Create your alert
to follow the executive moves at Galderma.
Household Products
EQT has 773 competitors including Unilever (United Kingdom (UK)), Lego (Denmark) and P&G (United States (USA)).
Popular M&A news in Household Products
- Galderma is now listed under the stock ticker GALD. (posted on March 22 2024).
- Scott's Liquid Gold and Horizon Kinetics have announced they will merge (posted on December 27 2023)..
- Nexus Capital Management has announced the acquisition of Dollar Shave Club (posted on October 31 2023).
Popular contacts in Household Products
News
Press releases by Galderma
- An organization built on uniqueness
- Celebrating Galderma’s listing on the SIX Swiss Exchange
- Galderma prices IPO at CHF 53 per share and will start trading on the SIX Swiss Exchange tomorrow
- Galderma announces full exercise of over-allotment option
- AMWC 2024: Scientific presentations supported by Galderma
- AMWC 2024: Galderma to share new data from its leading injectable aesthetic portfolio
- Galderma launches IPO on the SIX Swiss Exchange and sets price range
- Galderma @ AAD 2024: new data demonstrate the long-term efficacy of nemolizumab in prurigo nodularis and its durability in atopic dermatitis
- Dr. Flor A. Mayoral: A story of creativity, passion and dermatological innovation with Galderma
- We’re inspired by our people
- View more press releases Close
Social media about Galderma
- Galderma on Wikipedia, Google News & Yahoo Finance
- Galderma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Flemming Ornskov 
